title: [Use of low-molecular weight heparin during hemodialysis].
abstract: Coagulation parameters--platelet aggregation, beta-thromboglobulin, fibrinopeptide A were analyzes in patients with final chronic renal insufficiency during haemodialysis after a low molecular weight heparin application. In the study was documented that standard heparin is able to induce platelet aggregation. A low molecular weight heparin is suggested as sefex, because no influence on platelet aggregation was determined.
authors.affiliation: Kliniki Nefrologii Akademii Medycznej w Białymstoku.
authors.forename: M
authors.initials: M
authors.lastname: Kalinowski
authors.forename: K
authors.initials: K
authors.lastname: Pawlak
authors.forename: M
authors.initials: M
authors.lastname: Myśliwiec
authors.forename: A
authors.initials: A
authors.lastname: Popławski
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000379:methods
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight